Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
FATE
FULC
Add up to 3 more stocks
FATE
Fate Therapeutics, Inc.
-1.98%
$2.38-0.05Delayed quote: Oct 6, 2026, 12:05 PM EDT
Market Cap
$277.62M
52W Range
$0.95 - $3.23
FULC
Fulcrum Therapeutics, Inc.
+0.13%
$3.71+0.00Delayed quote: Oct 6, 2026, 12:05 PM EDT
Market Cap
$283.44M
52W Range
$2.83 - $15.74
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.81 | 0.91 |
| P/S Ratio | 42.77 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -94.1% | 0.0% |
| Operating Margin | -2222.4% | 0.0% |
| Net Margin | -1941.1% | 0.0% |
| ROE | -82.1% | -27.4% |
| ROA | -48.4% | -26.2% |
| ROIC | -58.7% | -27.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.85 | 31.35 |
| Quick Ratio | 4.85 | 31.35 |
| Debt/Equity | 0.49 | 0.02 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.